کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
4280797 | 1611564 | 2009 | 6 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Does magnetic resonance imaging accurately predict residual disease in breast cancer? Does magnetic resonance imaging accurately predict residual disease in breast cancer?](/preview/png/4280797.png)
BackgroundThe accuracy of magnetic resonance imaging (MRI) in identifying residual disease after breast conservation therapy (BCT) is unclear.MethodReview of an institutional database identified patients with positive or close (≤2 mm) margins undergoing MRI before re-excision. Histopathologic correlation was performed.ResultsForty-three women underwent MRI after BCT. MRI suggested residual disease in 29 patients, of whom 20 (69%) had residual carcinoma pathologically. Nine patients had false-positive MRI as seen by benign pathology findings. Fourteen MRIs indicated no residual disease, of which 6 had residual disease pathologically. The sensitivity and positive predictive value of MRI was 77% and 69%, respectively. MRI conducted within 28 days of the original surgery was 85% sensitive. MRI performed after 28 days was 69% sensitive.ConclusionsMRI is able to detect residual disease among most patients undergoing re-excision. False-positive results may be caused by inflammatory processes that resemble residual disease.
Journal: The American Journal of Surgery - Volume 198, Issue 4, October 2009, Pages 547–552